Robert Yordan, MD
Obstetrics & Gynecology · Middletown, CTNPI 1912001108
Payments from drug & device makers
Across 76 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$419
- Astellas Pharma US Inc$246
- Coopersurgical, Inc.$102
- Exeltis, USA Inc.$102
- Sumitomo Pharma America, Inc.$70
- Biohaven Pharmaceutical Holding Company Ltd.$62
- plus $433 from 13 others
What the payments were for
- Food & beverage$1,41899%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $419 |
| Astellas Pharma US Inc | 11 | $246 |
| Coopersurgical, Inc. | 6 | $102 |
| Exeltis, USA Inc. | 5 | $102 |
| Sumitomo Pharma America, Inc. | 4 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $62 |
| Pfizer | 4 | $57 |
| Therapeuticsmd, Inc. | 3 | $56 |
| Bayer | 3 | $52 |
| Evofem Biosciences, Inc. | 2 | $45 |
| Millicent US Inc | 2 | $38 |
| Agile Therapeutics, Inc. | 2 | $38 |
| Avion Pharmaceuticals | 2 | $29 |
| Lupin Inc. | 2 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Urovant Sciences Inc | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$1,434 in reported general payments places this provider in the 75th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 31 | $1,246 |
| FyavolvNorethindrone Ac/Eth Estradiol | 13 | $1,243 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $748 |
| Raloxifene Hcl | 19 | $721 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $596 |
| Oxybutynin Chloride | 12 | $227 |
| Fluconazole | 24 | $181 |
| ValacyclovirValacyclovir Hcl | 15 | $106 |
| Alprazolam | 16 | $12 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Middletown
- Alessandro SantinNew Haven$14.1M
- Mark LeondiresNorwalk$1.4M
- Alan FineHartford$974K
- Mary MinkinNew Haven$285K
- Elena RatnerNew Haven$119K
- Frederick RauHartford$89K
- Daniel WellingManchester$63K
- Peter AuerbachGroton$41K
- Sangini ShethNew Haven$39K
- Shieva GhofranyStamford$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.